| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial.
|
JAMA
|
2008
|
3.01
|
|
2
|
Comparison of two guideline-concordant antimicrobial combinations in elderly patients hospitalized with severe community-acquired pneumonia.
|
Crit Care Med
|
2012
|
2.38
|
|
3
|
Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia.
|
Am J Respir Crit Care Med
|
2011
|
2.30
|
|
4
|
The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia.
|
Respir Res
|
2005
|
2.18
|
|
5
|
Impact of statins and ACE inhibitors on mortality after COPD exacerbations.
|
Respir Res
|
2009
|
1.85
|
|
6
|
Systematic review of the use of retrievable inferior vena cava filters.
|
J Vasc Interv Radiol
|
2011
|
1.83
|
|
7
|
Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes.
|
Am J Respir Crit Care Med
|
2006
|
1.80
|
|
8
|
Technologic advances in endotracheal tubes for prevention of ventilator-associated pneumonia.
|
Chest
|
2012
|
1.77
|
|
9
|
Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes.
|
Clin Infect Dis
|
2012
|
1.75
|
|
10
|
Postoperative complications in the seriously mentally ill: a systematic review of the literature.
|
Ann Surg
|
2008
|
1.69
|
|
11
|
Severe pandemic H1N1 2009 influenza A infection: are we ready to move on?
|
Respirology
|
2011
|
1.50
|
|
12
|
Activity of a silver-coated endotracheal tube in preclinical models of ventilator-associated pneumonia and a study after extubation.
|
Crit Care Med
|
2010
|
1.42
|
|
13
|
Incidence, risk factors, and outcome of ventilator-associated pneumonia.
|
J Crit Care
|
2006
|
1.33
|
|
14
|
Outcome of reintubated patients after scheduled extubation.
|
J Crit Care
|
2011
|
1.23
|
|
15
|
Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit.
|
Clin Infect Dis
|
2011
|
1.22
|
|
16
|
Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.
|
Am J Med
|
2006
|
1.21
|
|
17
|
A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia.
|
Crit Care
|
2012
|
1.18
|
|
18
|
Incidence of cardiovascular events after hospital admission for pneumonia.
|
Am J Med
|
2011
|
1.10
|
|
19
|
Etiology of community-acquired pneumonia in hospitalized patients in chile: the increasing prevalence of respiratory viruses among classic pathogens.
|
Chest
|
2007
|
1.09
|
|
20
|
The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia.
|
Crit Care
|
2005
|
1.09
|
|
21
|
Impact of previous statin and angiotensin II receptor blocker use on mortality in patients hospitalized with sepsis.
|
Pharmacotherapy
|
2007
|
0.99
|
|
22
|
Antibiotic therapy and 48-hour mortality for patients with pneumonia.
|
Am J Med
|
2006
|
0.99
|
|
23
|
Prognosis factors and outcome of community-acquired pneumonia needing mechanical ventilation.
|
J Crit Care
|
2005
|
0.96
|
|
24
|
Predictors of long-term mortality after severe sepsis in the elderly.
|
Am J Med Sci
|
2014
|
0.92
|
|
25
|
Disparities of care for African-Americans and Caucasians with community-acquired pneumonia: a retrospective cohort study.
|
BMC Health Serv Res
|
2010
|
0.92
|
|
26
|
Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
|
Clin Ther
|
2010
|
0.92
|
|
27
|
Strategies in the prevention of ventilator-associated pneumonia.
|
Ther Adv Respir Dis
|
2011
|
0.90
|
|
28
|
Community-Acquired Pneumonia Requiring Hospitalization.
|
N Engl J Med
|
2015
|
0.90
|
|
29
|
Lung transplantation for Williams-Campbell syndrome with a probable familial association.
|
Respir Care
|
2012
|
0.89
|
|
30
|
Pulmonary disease among inpatient decedents: Impact of schizophrenia.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2007
|
0.88
|
|
31
|
Community-acquired pneumonia in elderly patients.
|
Aging health
|
2009
|
0.88
|
|
32
|
Association of hypoglycemia with mortality for subjects hospitalized with pneumonia.
|
Am J Med Sci
|
2010
|
0.87
|
|
33
|
Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy.
|
Clin Infect Dis
|
2005
|
0.87
|
|
34
|
Pulmonary mucormycosis: what is the best strategy for therapy?
|
Respir Care
|
2013
|
0.86
|
|
35
|
Impact of obesity on outcomes for patients hospitalised with pneumonia.
|
Eur Respir J
|
2012
|
0.86
|
|
36
|
Diagnosis of pulmonary malignancy after hospitalization for pneumonia.
|
Am J Med
|
2010
|
0.85
|
|
37
|
The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia.
|
BMC Pulm Med
|
2005
|
0.84
|
|
38
|
Hypocapnia and hypercapnia are predictors for ICU admission and mortality in hospitalized patients with community-acquired pneumonia.
|
Chest
|
2012
|
0.84
|
|
39
|
[Non-pharmacological prevention of ventilator-associated pneumonia].
|
Arch Bronconeumol
|
2009
|
0.84
|
|
40
|
Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia.
|
Eur Respir J
|
2013
|
0.84
|
|
41
|
Somatic Cough Syndrome (Previously Referred to as Psychogenic Cough) and Tic Cough (Previously Referred to as Habit Cough) in Adults and Children: CHEST Guideline and Expert Panel Report.
|
Chest
|
2015
|
0.83
|
|
42
|
Pneumonia: an arrhythmogenic disease?
|
Am J Med
|
2012
|
0.83
|
|
43
|
A clinical pathway for community-acquired pneumonia: an observational cohort study.
|
BMC Infect Dis
|
2011
|
0.82
|
|
44
|
A model for increasing palliative care in the intensive care unit: enhancing interprofessional consultation rates and communication.
|
J Pain Symptom Manage
|
2011
|
0.82
|
|
45
|
Impact of prior outpatient antibiotic use on mortality for community acquired pneumonia: a retrospective cohort study.
|
BMC Res Notes
|
2008
|
0.82
|
|
46
|
Predicting ICU admission in community-acquired pneumonia: clinical scores and biomarkers.
|
Expert Rev Clin Pharmacol
|
2012
|
0.82
|
|
47
|
What is the best antimicrobial treatment for severe community-acquired pneumonia (including the role of steroids and statins and other immunomodulatory agents).
|
Infect Dis Clin North Am
|
2012
|
0.81
|
|
48
|
Mortality and regional oxygen saturation index in septic shock patients: a pilot study.
|
J Trauma
|
2011
|
0.81
|
|
49
|
Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia.
|
Infect Drug Resist
|
2012
|
0.80
|
|
50
|
Hypoxemia adds to the CURB-65 pneumonia severity score in hospitalized patients with mild pneumonia.
|
Respir Care
|
2011
|
0.79
|
|
51
|
Pneumonia in the elderly hospitalized in the Department of Veteran Affairs Health Care System.
|
Mil Med
|
2011
|
0.78
|
|
52
|
Corticosteroids for Severe Community-Acquired Pneumonia: Time to Change Clinical Practice.
|
Ann Intern Med
|
2015
|
0.78
|
|
53
|
Novel targets in the management of pneumonia.
|
Ther Adv Respir Dis
|
2008
|
0.78
|
|
54
|
Evaluation of the IDSA/ATS minor criteria for severe community-acquired pneumonia.
|
Hosp Pract (1995)
|
2012
|
0.78
|
|
55
|
THE PARADOXICAL EFFECT ON PNEUMONIA OF CHRONIC INHALED CORTICOSTEROIDS.
|
Clin Pulm Med
|
2013
|
0.78
|
|
56
|
Improving the 2007 Infectious Disease Society of America/American Thoracic Society severe community-acquired pneumonia criteria to predict intensive care unit admission.
|
J Crit Care
|
2012
|
0.78
|
|
57
|
Year in review 2013: Lung cancer, respiratory infections, tuberculosis, cystic fibrosis, pleural diseases, bronchoscopic intervention and imaging.
|
Respirology
|
2014
|
0.77
|
|
58
|
Chromogranin A levels and mortality in patients with severe sepsis.
|
Biomarkers
|
2015
|
0.77
|
|
59
|
Effects of inhaled corticosteroids on pneumonia severity and antimicrobial resistance.
|
Respir Care
|
2013
|
0.77
|
|
60
|
Methicillin-resistant Staphylococcus aureus guidelines: a myriad of open questions.
|
Clin Infect Dis
|
2011
|
0.77
|
|
61
|
Risk factors and antibiotic therapy in P. aeruginosa community-acquired pneumonia.
|
Respirology
|
2015
|
0.76
|
|
62
|
Impact of macrolide therapy in patients hospitalized with Pseudomonas aeruginosa community-acquired pneumonia.
|
Chest
|
2014
|
0.76
|
|
63
|
Assessment of Intervention Fidelity and Recommendations for Researchers Conducting Studies on the Diagnosis and Treatment of Chronic Cough in the Adult: CHEST Guideline and Expert Panel Report.
|
Chest
|
2015
|
0.76
|
|
64
|
Statins and outcomes in patients with pneumonia: not only healthy user bias.
|
BMJ
|
2006
|
0.76
|
|
65
|
Preventing ventilator associated pneumonia: looking beyond the bundles.
|
Clin Infect Dis
|
2011
|
0.75
|
|
66
|
Year in review 2011: respiratory infections, tuberculosis, pleural diseases, bronchoscopic intervention and imaging.
|
Respirology
|
2012
|
0.75
|
|
67
|
When to switch therapy in patients with severe community-acquired pneumonia.
|
Ann Intern Med
|
2008
|
0.75
|
|
68
|
Corticosteroids for pneumonia: are we there yet?
|
Respirology
|
2013
|
0.75
|
|
69
|
The authors reply.
|
Crit Care Med
|
2013
|
0.75
|
|
70
|
Year in review 2012: lung cancer, respiratory infections, tuberculosis, pleural diseases, bronchoscopic intervention and imaging.
|
Respirology
|
2013
|
0.75
|
|
71
|
Is it possible to predict which patients with mild pneumonias will develop hypoxemia?
|
Respir Med
|
2009
|
0.75
|
|
72
|
Understanding the Concept of Health Care-Associated Pneumonia in Lung Transplant Recipients.
|
Chest
|
2015
|
0.75
|
|
73
|
Too passive to prevent ventilator-associated pneumonia.
|
Respir Care
|
2013
|
0.75
|
|
74
|
Steroid infusion for severe pneumonia: not so fast...
|
Am J Respir Crit Care Med
|
2005
|
0.75
|
|
75
|
Is N-terminal pro-B-type natriuretic peptide ready for 'prime time' in severe pneumonia?
|
Respirology
|
2013
|
0.75
|
|
76
|
Reply to Bodi et al.
|
Clin Infect Dis
|
2006
|
0.75
|
|
77
|
[Pharmacologic measures for the prevention of mechanical ventilation-associated pneumonia].
|
Med Clin (Barc)
|
2010
|
0.75
|
|
78
|
Association of hydrophilic versus lipophilic angiotensin-converting enzyme inhibitor use on pneumonia-related mortality.
|
Am J Med Sci
|
2008
|
0.75
|
|
79
|
Does prolonged onset of symptoms have a prognostic significance in community-acquired pneumonia?
|
Respirology
|
2014
|
0.75
|
|
80
|
Multidrug-resistant pathogens in patients with pneumonia coming from the community.
|
Curr Opin Pulm Med
|
2016
|
0.75
|
|
81
|
Community-acquired pneumonia team decreases length of stay in hospitalized, low-risk patients with pneumonia.
|
Hosp Pract (1995)
|
2013
|
0.75
|
|
82
|
Evaluation of ICU admission criteria and diagnostic methods for patients with severe community-acquired pneumonia: current practice survey.
|
Chest
|
2008
|
0.75
|
|
83
|
Impact of prior systemic corticosteroid use in patients admitted with community-acquired pneumonia.
|
Ther Adv Respir Dis
|
2012
|
0.75
|